FOLEY & LARDNER LLP

Lobbying for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY · pharmaceutical manufacturing

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $70,000.00 income · posted Apr 17, 2025

Lobbying activity 2

Pharmacy

Issues related to Domestic manufacturing; Issues related to 340B; implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill; Issues related to supply chain resilience.

Health Issues

Issues related to Domestic manufacturing; Issues related to 340B; implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill; Issues related to supply chain resilience.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.